Anticoagulation Therapy

DRUG5 trials

Conditions

Atrial FibrillationCerebral Venous Sinus ThrombosisPortal vein thrombosis, Liver cirrhosisPost-Operative Atrial FibrillationStroke, IschemicVenous Thromboembolism

Early Phase 1

Statin Use in Patients With Acute VTE

TerminatedNCT02331095

Ohio State UniversityVenous Thromboembolism

Start: 2015-01-31End: 2020-05-20Updated: 2020-10-19

Phase 4

AtriClip® Left Atrial Appendage Exclusion Concomitant to Structural Heart Procedures (ATLAS)

CompletedNCT02701062

AtriCure, Inc.Post-Operative Atrial Fibrillation

Start: 2016-02-29End: 2019-06-01Updated: 2021-11-24

Unknown Phase

Atrial Fibrillation Burden and Long-term Risk of Thromboembolic Complications- the FinCV-4 Study

Active, not recruitingNCT04001205

University of TurkuAtrial Fibrillation, Stroke, Ischemic

Start: 2019-06-01End: 2025-01-08Target: 1300Updated: 2024-05-08

Study on the correlation between intestinal microbiota and portal vein thrombosis and cirrhosis

RecruitingJPRN-UMIN000043536

Kanazawa UniversityPortal vein thrombosis, Liver cirrhosis

Start: 2020-08-14Target: 40Updated: 2026-06-29

MENA Regional Endovascular Intervention for Venous Cerebral Venous Sinus Thrombosis

Not yet recruitingNCT07548346

Middle East North Africa Stroke and Interventional Neurotherapies OrganizationCerebral Venous Sinus Thrombosis

Start: 2026-07-01End: 2030-01-01Target: 440Updated: 2026-04-23

Related Papers

Left atrial appendage occlusion for patients with valvular diseases without atrial fibrillation (the OPINION Study): study protocol for a multicentre, randomised controlled trial

BMJ Open2024-02-011 citations

Prophylactic Left Atrial Appendage Exclusion in Cardiac Surgery Patients With Elevated CHA <sub>2</sub> DS <sub>2</sub> -VASc Score: Results of the Randomized ATLAS Trial